Innerspace, an Innsbruck, Austria-based tech startup that enables risk assessment of production processes and effective training of cleanroom personnel for pharmaceutical companies using software and Virtual Reality (VR), raised €5.7M in funding.
The round was led by Matterwave Ventures, with participation from MAD Ventures, aws Gründungsfonds, and High-Tech Gründerfonds.
The company intends to use the funds to expand its international market presence and further develop its unique “Frame-by-Frame” technology.
Innerspace focuses on risk assessment and effective training of cleanroom personnel for pharmaceutical companies. Through the targeted use of psychological insights and innovative technologies, the company aims to minimize errors in pharmaceutical processes and reduce risks. This includes the proprietary method of “Frame-by-Frame Risk Profiling” for comprehensive risk assessment, as well as a standardized cleanroom simulator for personnel training in virtual reality. In its role as an official partner of the Parenteral Drug Association (PDA), Innerspace actively engages in the development and implementation of high-quality training courses for the pharmaceutical industry.
FinSMEs
19/02/2024